EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Clinical phage microbiology: a narrative summary

Gina A Suh, Robin Patel

Clinical Microbiology and Infection · 2023

DOI: 10.1016/j.cmi.2023.02.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology and Infection, 2023. Verfasst von Gina A Suh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA. Electronic addres…. Hauptthemen laut MEDLINE: Bacteriophages. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: TenNor Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although phage therapy has been in existence for a century, a recent resurgence in interest has occurred because of the continued emergence of antimicrobial resistance and the rising use of indwelling medical devices, resulting in biofilm-associated infections, for which conventional antibiotics are of limited use. Despite this, the clinical successes have been inconsistent because of multiple reasons, including (1) the narrow host range of phages, (2) challenges with concentrating phages at the site of infection, (3) development of resistance of bacteria to phages and (4) immune neutralization. Microbiologic assays have the potential to help guide the course of clinical therapy and improve outcomes. Methods developed decades ago remain the mainstay of phage diagnostics and recently, newer diagnostics are closing the gap needed to further advance clinical phage therapy. OBJECTIVES: To review the current state of clinical phage microbiology and identify gaps. SOURCES: A PubMed search was performed using the terms "phage microbiology", "phage susceptibility test", "phage host range", "phage biofilm", and "phage therapeutic monitoring". CONTENT: Phage susceptibility testing, biofilm assays, phage-antibiotic combination testing, therapeutic drug monitoring, and immune monitoring assays are the current foundation for clinical phage diagnostics. Standardization of these assays and better understanding as to if and how they should be used in terms of clinical management of patients receiving phage therapy is needed. IMPLICATIONS: A substantial gap between in vitro studies and in vivo outcomes indicates that further work is needed in phage pharmacokinetics to accurately assay phage particles at the site of infection; recapitulate in vivo biofilm; capture the complex interactions between phages and antibiotics, phages and their target bacteria, among phages in a cocktail, and with the superhost immune system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriophagesHumansBacteriaBiofilmsHost SpecificityAnti-Bacterial Agents

Stichwörter der Autor:innen

BiofilmsPhage susceptibility testingPhagesTherapeutic monitoring

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: suh.gina@mayo.edu.
  • Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, May…

Förderung

  • TenNor Therapeutics

Zitieren

APA

Suh, G. A., & Patel, R. (2023). Clinical phage microbiology: a narrative summary. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.02.006

Vancouver

Suh GA, Patel R. Clinical phage microbiology: a narrative summary. Clinical Microbiology and Infection. 2023. doi:10.1016/j.cmi.2023.02.006

BibTeX
@article{Suh2023,
  author = {Suh, Gina A and Patel, Robin},
  title = {Clinical phage microbiology: a narrative summary},
  journal = {Clinical Microbiology and Infection},
  year = {2023},
  doi = {10.1016/j.cmi.2023.02.006}
}
Kostenlos starten →